moderna-recalling-vaccine-lot-in-europe-due-to-foreign-body-found-in-vial

Moderna Recalls Vaccine Lot in Europe Due to ‘Foreign Body’ Found in Vial


Moderna—the company that literally never brought a product to market prior to Warp Speed—has recalled a “vaccine” lot in Europe due to a “foreign body” found in one of the vials.


Moderna Inc., a biotech company founded in 2011 and headquartered in Cambridge, Massachusetts, has voluntarily recalled a batch of its Spikevax “vaccine”—the same COVID-19 mRNA vaccine available in the U.S., but with a different brand name—in Europe. The batch, which contained 764,900 doses made by Spanish subcontractor CDMO Rovi, were deployed across Poland, Norway Portugal, Spain, and Sweden between January 13-14, 2022.

“The lot is being recalled due to a foreign body being found in one vial in the lot manufactured at the Company’s contract manufacturing site, ROVI, in Spain,” Moderna wrote in a press release. “The impacted vial was punctured and was not administered,” the company added.

According to Moderna, the company has “conducted a cumulative search of its global safety database, and no safety concerns were reported in individuals who received the Moderna COVID-19 vaccine from this lot.” The company adds that “To date, no safety or efficacy issues have been identified.”

Moderna provides no insight into what the “foreign body” may be, nor whether or not it was likely in the vial before or after it was punctured. Indeed, there is no discussion of how the vial was punctured, nor what could be done to prevent similar puncturing in other vials.

The company “does not believe that this [recall] poses a risk to other vials in the lot and does not believe that this affects the significant benefit/risk profile of the vaccine,” Moderna says.

This isn’t the first time Moderna has recalled one of its lots. As Reuters reported on September 1, 2021, Japanese authorities suspended 1.63 million doses of Moderna’s “vaccine” in total “after being notified of [a] contamination issue.”

The Japanese health ministry reported that two men—age 38 and 30—died within days of receiving their second Moderna doses from one of the suspended lots. Although the healthy ministry said the link between the two was “coincidental.”


Feature image: Navy Medicine

(Visited 1 times, 1 visits today)

Accessibility Toolbar